Abstract
Directly acting fibrinolytic enzyme is found to be superior therapy for treatment of cardiovascular diseases. Hence, thereis a need of a novel and highly potent fibrinolytic agent which can directly degrade fibrin clot in lesser time withimproved specificity and overcome shortcomings of haemorrhage. Amongst various sources, microbial fibrinolyticenzymes have attracted attention of research community so the present study aimed to isolate fibrinolytic enzymeproducingbacteria from different soil samples. Caseinolytic activity and clot lyses activity of the crude enzyme producedby these isolates were determined. All together six caseinolytic organisms were isolated, 3 of them produced fibrinolyticprotease which would lyse fibrin and whole blood clot. Caseinolytic activity in the crude enzyme preparation fromColony C₄ was detected to be 78.2 U/ml and was able to lyse 85.54% of whole blood clot in 90 mins. Colony 4 may beof potential interest for biotechnological use as it produces fibrinolytic proteases that degraded fibrin clot and the wholeblood clot, to the maximum.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.